Product Summary

Cat. No.
ST001
Test Method
Particle-enhanced turbidimetric immunoassay (PETIA)
Assay range
50 ng/mL to 3000 ng/mL (Can vary based on analyzer model)
Assay time
10 minutes (Hitachi 917) (Can vary based on analyzer model)
Content
1 x NGAL Buffer Solution (R1), 35 mL, 1 x NGAL latex suspension (R2), 7 mL
Form
Ready-to-use solution
Shelf life
24 months from manufacturing. See expiry date on the label
Storage after opening
Open vial stability 30 days, On board stability 30 days (when refrigerated)
Background
The NGAL Test™ is a particle-enhanced turbidimetric immunoassay for the quantitative determination of neutrophil gelatinase-associated lipocalin (NGAL) in human urine, EDTA plasma or heparin plasma on automated clinical chemistry analyzers. The NGAL Test™ Calibrator Kit contains calibrator solutions for establishing the calibration curve. NGAL measurements are useful in the diagnosis of acute kidney injury which may lead to acute renal failure.
Regulatory status
Not available in the USA for in vitro diagnostic use. For in vitro diagnostic use in the European Union, Canada, Korea and Israel. For research use only in all other territories.
Patent status
This product is protected by one or more US, European and/or foreign patents.

Scientific References

Itenov TS, Bangert K, Christensen PH, Jensen JU, Bestle MH (2014) Serum and Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) Levels are Not Equivalent in Patients Admitted to Intensive Care. J Clin Lab Anal. 28:163-167

 

Hansen YB, Damgaard A, Poulsen JH (2013) Evaluation of NGAL TestTM on Cobas 6000. Scand J Clin Lab Invest. 74:20-26

 

Allavena C, Bach-Ngohou K, Billaud E, Secher S, Dejoie T, Reliquet V, Fakhouri F, Raffi F (2013) Neutrophil gelatinase-associated lipocalin, a marker of tubular dysfunction, is not increased in long-term virologically controlled patients receiving a tenofovir/emtricitabine + nevirapine regimen. J Antimicrob Chemother. 68:2866-2870

 

Feldheiser A, Pavlova V, Bonomo T, Jones A, Fotopoulou C, Sehouli J, Wernecke KD, Spies C (2013) Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth. 110:231-240

 

Seo Y, Lee W, Kwon OH (2013) Performance Evaluation of BioPorto Diagnostics’ Neutrophil Gelatinase-associated Lipocalin Assay on Automated Clinical Chemistry Analyzer Hitachi 7600. J Lab Med Qual Assur. 35:23-28

Cat. No.
ST001
Test Method
Particle-enhanced turbidimetric immunoassay (PETIA)
Assay range
50 ng/mL to 3000 ng/mL (Can vary based on analyzer model)
Assay time
10 minutes (Hitachi 917) (Can vary based on analyzer model)
Content
1 x NGAL Buffer Solution (R1), 35 mL, 1 x NGAL latex suspension (R2), 7 mL
Form
Ready-to-use solution
Shelf life
24 months from manufacturing. See expiry date on the label
Storage after opening
Open vial stability 30 days, On board stability 30 days (when refrigerated)
Background
The NGAL Test™ is a particle-enhanced turbidimetric immunoassay for the quantitative determination of neutrophil gelatinase-associated lipocalin (NGAL) in human urine, EDTA plasma or heparin plasma on automated clinical chemistry analyzers. The NGAL Test™ Calibrator Kit contains calibrator solutions for establishing the calibration curve. NGAL measurements are useful in the diagnosis of acute kidney injury which may lead to acute renal failure.
Regulatory status
Not available in the USA for in vitro diagnostic use. For in vitro diagnostic use in the European Union, Canada, Korea and Israel. For research use only in all other territories.
Patent status
This product is protected by one or more US, European and/or foreign patents.

Itenov TS, Bangert K, Christensen PH, Jensen JU, Bestle MH (2014) Serum and Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) Levels are Not Equivalent in Patients Admitted to Intensive Care. J Clin Lab Anal. 28:163-167

 

Hansen YB, Damgaard A, Poulsen JH (2013) Evaluation of NGAL TestTM on Cobas 6000. Scand J Clin Lab Invest. 74:20-26

 

Allavena C, Bach-Ngohou K, Billaud E, Secher S, Dejoie T, Reliquet V, Fakhouri F, Raffi F (2013) Neutrophil gelatinase-associated lipocalin, a marker of tubular dysfunction, is not increased in long-term virologically controlled patients receiving a tenofovir/emtricitabine + nevirapine regimen. J Antimicrob Chemother. 68:2866-2870

 

Feldheiser A, Pavlova V, Bonomo T, Jones A, Fotopoulou C, Sehouli J, Wernecke KD, Spies C (2013) Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth. 110:231-240

 

Seo Y, Lee W, Kwon OH (2013) Performance Evaluation of BioPorto Diagnostics’ Neutrophil Gelatinase-associated Lipocalin Assay on Automated Clinical Chemistry Analyzer Hitachi 7600. J Lab Med Qual Assur. 35:23-28

More Information

+

BioPorto is proud to offer a range of products to help scientists and clinicians better understand kidney damage, from drug discovery to preclinical and clinical research to patient care.

Other Products

×